71 related articles for article (PubMed ID: 2429414)
1. [Bleomycin-induced pulmonary toxicity and related factors to that toxicity in experimental animals].
Okayama H
Tsurumi Shigaku; 1986 May; 12(2):245-57. PubMed ID: 2429414
[No Abstract] [Full Text] [Related]
2. [Experimentally induced bleomycin pulmonary toxicity--comparison of the systemic (intraperitoneal) and local (intratracheal) administration].
Ekimoto H; Takahashi K; Matsuda A; Umezawa H
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2550-7. PubMed ID: 6197032
[TBL] [Abstract][Full Text] [Related]
3. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis.
Harrison JH; Lazo JS
J Pharmacol Exp Ther; 1988 Dec; 247(3):1052-8. PubMed ID: 2462625
[TBL] [Abstract][Full Text] [Related]
4. [Changes of anticancer activity and pulmonary toxicity of bleomycins in differences of administration schedules and routes in mice].
Ekimoto H; Takahashi K; Matsuda A; Umezawa H
Gan To Kagaku Ryoho; 1984 Apr; 11(4):853-7. PubMed ID: 6202241
[TBL] [Abstract][Full Text] [Related]
5. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis.
Haston CK; Travis EL
Cancer Res; 1997 Dec; 57(23):5286-91. PubMed ID: 9393751
[TBL] [Abstract][Full Text] [Related]
6. Murine strain differences in pulmonary bleomycin metabolism.
Filderman AE; Lazo JS
Biochem Pharmacol; 1991 Jun; 42(1):195-8. PubMed ID: 1712591
[No Abstract] [Full Text] [Related]
7. Bleomycin-induced pulmonary fibrosis susceptibility genes in AcB/BcA recombinant congenic mice.
Lemay AM; Haston CK
Physiol Genomics; 2005 Sep; 23(1):54-61. PubMed ID: 16179420
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
Cabrera S; Gaxiola M; Arreola JL; RamÃrez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG).
Molina V; Haj-Yahia S; Solodeev I; Levy Y; Blank M; Shoenfeld Y
Autoimmunity; 2006 Dec; 39(8):711-7. PubMed ID: 17178568
[TBL] [Abstract][Full Text] [Related]
10. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
11. [DNA strand breaks in epithelial cells from mice with bleomycin induced pulmonary fibrosis].
Hagimoto N; Kuwano K; Nomoto Y; Kunitake R; Hashimoto S; Hara N
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):3-8. PubMed ID: 8717284
[TBL] [Abstract][Full Text] [Related]
12. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
13. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice.
Harrison JH; Hoyt DG; Lazo JS
Mol Pharmacol; 1989 Aug; 36(2):231-8. PubMed ID: 2475758
[TBL] [Abstract][Full Text] [Related]
14. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice.
Filderman AE; Genovese LA; Lazo JS
Biochem Pharmacol; 1988 Mar; 37(6):1111-6. PubMed ID: 2451525
[TBL] [Abstract][Full Text] [Related]
15. [Steroid resistance and lung-tissue cytokines in experimental bleomycin-induced lung fibrosis].
Hosoya T
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jul; 35(7):766-75. PubMed ID: 9341282
[TBL] [Abstract][Full Text] [Related]
16. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice.
Hoyt DG; Lazo JS
J Pharmacol Exp Ther; 1988 Aug; 246(2):765-71. PubMed ID: 2457084
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
19. Animal models of pulmonary fibrosis.
Gharaee-Kermani M; Ullenbruch M; Phan SH
Methods Mol Med; 2005; 117():251-9. PubMed ID: 16118457
[TBL] [Abstract][Full Text] [Related]
20. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.
Lazo JS; Humphreys CJ
Proc Natl Acad Sci U S A; 1983 May; 80(10):3064-8. PubMed ID: 6190169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
